Glycaemia and utilisation of technology across the lifespan of adults with type 1 diabetes: Results of the Australian National Diabetes Audit (ANDA)
Anthony Pease, Naomi Szwarcbard, Arul Earnest, Sofianos Andrikopoulos, Natalie Wischer, Sophia Zoungas
DIABETES RESEARCH AND CLINICAL PRACTICE | ELSEVIER IRELAND LTD | Published : 2021
AIMS: To evaluate the utilisation of technologies and associated glycaemia among adults with type 1 diabetes. METHODS: De-identified data from adults with type 1 diabetes (≥18 years old) in the Australian National Diabetes Audit (ANDA)-2019 were analysed. Proportions using insulin pumps or injections with continuous glucose monitoring (CGM) or capillary-glucose testing were compared. Technology use among adults was compared to young people (<21 years old) with subsidised CGM. Glycaemia and complication-burden were assessed across management strategies. RESULTS: 1,693 adults were analysed. Mean(±SD) age, diabetes duration, and HbA1c were 43.3 ± 17.0 years, 20.3 ± 14.3 years and 8.4% ± 1.7 [68..View full abstract
The Commonwealth Department of Health and Ageing funds the Australian National Diabetes Audit. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for profit sectors.